These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1496 related items for PubMed ID: 18401260

  • 1. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.
    Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [Abstract] [Full Text] [Related]

  • 2. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I, McShane P, Koo DD, Gray D, Friend PJ, Fuggle S, Darby C.
    Nephrol Dial Transplant; 2006 Jun 15; 21(6):1689-96. PubMed ID: 16490743
    [Abstract] [Full Text] [Related]

  • 3. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 4. Duration of delayed graft function is an important predictor of 1-year serum creatinine.
    Domínguez J, Lira F, Rebolledo R, Troncoso P, Aravena C, Ortiz M, Gonzalez R.
    Transplant Proc; 2009 Jul 27; 41(1):131-2. PubMed ID: 19249496
    [Abstract] [Full Text] [Related]

  • 5. Impact of cold ischemia time on renal allograft outcome using kidneys from young donors.
    Hernández D, Estupiñán S, Pérez G, Rufino M, González-Posada JM, Luis D, Delgado P, Rodríguez A, Marrero D, Porrini E, Torres A.
    Transpl Int; 2008 Oct 27; 21(10):955-62. PubMed ID: 18564990
    [Abstract] [Full Text] [Related]

  • 6. Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.
    Vilar E, Varagunam M, Yaqoob MM, Raftery M, Thuraisingham R.
    Transplantation; 2010 Jan 15; 89(1):97-103. PubMed ID: 20061925
    [Abstract] [Full Text] [Related]

  • 7. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Jan 15; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 8. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug 15; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ, Alloway RR, Lo A, Hodge EE.
    Transplant Proc; 2005 Oct 15; 37(8):3527-30. PubMed ID: 16298650
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Oct 15; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
    Sáinz MM, Toro JC, Poblete HB, Perez LF, Nicovani VH, Carrera MG.
    Transplant Proc; 2009 Oct 15; 41(6):2655-8. PubMed ID: 19715994
    [Abstract] [Full Text] [Related]

  • 14. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R, Yagmurdur MC, Karakayali F, Haberal C, Ozcelik U, Colak T, Haberal M.
    Transplant Proc; 2005 Sep 15; 37(7):2954-6. PubMed ID: 16213272
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Sep 15; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ, da Silva Quadros KR, Santos RL, Alves-Filho G, Mazzali M.
    Transplant Proc; 2009 Apr 15; 41(3):849-51. PubMed ID: 19376369
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L, Fonseca I, Almeida M, Henriques AC, Dias L, Sarmento AM, Cabrita A.
    Transplant Proc; 2005 Apr 15; 37(6):2755-8. PubMed ID: 16182802
    [Abstract] [Full Text] [Related]

  • 19. [Cold ischaemia time and outcome of renal transplantation].
    Warlé MC, Cheung CL, Teerenstra S, Hoitsma AJ, van der Vliet JA.
    Ned Tijdschr Geneeskd; 2010 Apr 15; 154():B539. PubMed ID: 20298635
    [Abstract] [Full Text] [Related]

  • 20. Impact of delayed graft function and acute rejection on kidney graft survival.
    Gjertson DW.
    Clin Transpl; 2000 Apr 15; ():467-80. PubMed ID: 11512359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.